[Form 4] EDGEWELL PERSONAL CARE Co Insider Trading Activity

Rhea-AI Filing Summary

Edgewell Personal Care Company reported an equity award to one of its officers on Form 4. The reporting person, who serves as President, North America, received 26,476 restricted stock equivalents (RSEs) tied to Edgewell common stock on 11/14/2025 at an exercise price of $0.

According to the vesting terms, one-third of these RSEs will convert into shares of Edgewell common stock on each of 11/14/2026, 11/14/2027 and 11/14/2028, as long as the officer remains employed on those dates. All or a portion of the RSEs may vest earlier upon death, disability, a change in control, or certain termination events.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SPENCE JESSICA

(Last) (First) (Middle)

C/O EDGEWELL PERSONAL CARE COMPANY

6 RESEARCH DRIVE

(Street)

SHELTON CT 06484

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EDGEWELL PERSONAL CARE Co [ EPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, North America

3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock	$0	11/14/2025		A		26,476		11/14/2026	(1)	Common Stock	26,476	$0	26,476	D

Explanation of Responses:

1. One-third of the RSEs will vest and convert into shares of Edgewell common stock on each of 11/14/2026, 11/14/2027 and 11/14/2028 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events.

	/s/ Jessica Spence	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did EDGEWELL PERSONAL CARE (EPC) report on this Form 4?

The company reported that an officer received 26,476 restricted stock equivalents (RSEs) linked to Edgewell common stock on 11/14/2025 at an exercise price of $0.

Who is the reporting person in the EPC Form 4 filing and what is their role?

The reporting person is an officer of Edgewell Personal Care Company, serving as President, North America, as disclosed in the relationship section of the filing.

How do the 26,476 RSEs granted by EDGEWELL PERSONAL CARE (EPC) vest?

One-third of the 26,476 RSEs will vest and convert into Edgewell common stock on each of 11/14/2026, 11/14/2027 and 11/14/2028, subject to continued employment on those dates.

Are there circumstances under which the EPC RSEs can vest earlier?

Yes. The filing states that all or a portion of the RSEs may vest earlier upon death, disability, a change in control, or certain termination events.

What type of derivative security is reported in the EPC Form 4?

The Form 4 lists restricted stock equivalents (RSEs) as derivative securities that are convertible into Edgewell common stock, with 26,476 underlying shares referenced.

Is the EDGEWELL PERSONAL CARE (EPC) Form 4 filed by a single reporting person or a group?

The filing is identified as a Form filed by one reporting person, not by a joint or group filer.